Usefulness of the SYNTAX Score to Predict “No Reflow” in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Usefulness of Serum Albumin Concentration to Predict High Coronary SYNTAX Score and In-Hospital Mortality in Patients With Acute Coronary Syndrome

“…[1][2][3][4][5][6][7] Palmerini and colleagues 3 demonstrated that the SYNTAX score is an independent predictor of the 1-year rates of death, cardiac death, myocardial infarction, and target vessel revascularization in patients with ACS who underwent PCI. Magro et al 5 showed a relation between SYNTAX score and the development of no reflow in patients treated with primary PCI for STEMI.…”

“…[1][2][3][4][5][6][7] Palmerini and colleagues 3 demonstrated that the SYNTAX score is an independent predictor of the 1-year rates of death, cardiac death, myocardial infarction, and target vessel revascularization in patients with ACS who underwent PCI. Magro et al 5 showed a relation between SYNTAX score and the development of no reflow in patients treated with primary PCI for STEMI. In large study, Madhavan et al 6 investigated the relationship between the SYNTAX score and acute kidney injury (AKI) after PCI for NSTE-ACS and they found that the SYN-TAX score was independently associated with AKI, and patients who developed AKI experienced worse short-term and long-term outcomes.…”

“…1 Numerous studies have confirmed the higher SYN-TAX score to be an independent predictor of increased shortand long-term morbidity and mortality in patients with acute coronary syndromes (ACSs). [2][3][4][5][6][7] Thus, identifying patients with high SYNTAX score may be important in terms of getting prognostic information. The pathogenesis of atherosclerosis involves a number of mechanisms, including inflammation, endothelial dysfunction, oxidative stress, and platelet activation.…”

The utility of the TIMI risk index on admission for predicting angiographic no-reflow after primary percutaneous coronary intervention in patients with STEMI

“…The invention and usage of stents have made percutaneous coronary intervention (PCI) a safe, effective, and preferred treatment of ST-segment elevation myocardial infarction (STEMI) (2). However, even after patency of an infarcted artery was successfully achieved via stent implantation, sufficient myocardial reperfusion was not observed in 2.3% to 29% of patients in the setting of AMI, often called the no-reflow (NRF) phenomenon (3)(4)(5). Despite the mechanical opening of the infarct-related artery (IRA), early postinfarction complications and in-hospital long-term morbidity and mortality rates increased in patients who developed NRF (6)(7)(8).…”

Retraction Notice

“…12 The SXscore is not only able to aid revascularization decisions but also able to predict early and late mortality/morbidity in patients with ACS. [13][14][15] Recently, the MPV-to-lymphocyte ratio (MPVLR) has emerged as a prognostic marker in patients with ST-segment elevation MI (STEMI). 16 More recently, we have found that elevated MPVLR values at admission are independently associated with the development of no-reflow phenomenon after primary percutaneous coronary intervention (PCI) in patients presenting with acute STEMI.…”